We revealed that RDH13, CLDN11, TMTC1, UCHL1, and FOXP2 can serve as predictive biomarkers for gastric cancer treatment and the promoter methylation level of these five genes in serum could have prognostic and diagnostic functions in gastric cancer patients. Here, CLDN11 is linked to gastric cancer.